Your browser doesn't support javascript.
loading
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.
Patel, Jai N; Robinson, Myra; Morris, Sarah A; Jandrisevits, Elizabeth; Lopes, Karine Eboli; Hamilton, Alicia; Steuerwald, Nury; Druhan, Lawrence J; Avalos, Belinda; Copelan, Edward; Ghosh, Nilanjan; Grunwald, Michael R.
Afiliación
  • Patel JN; Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Jai.Patel@atriumhealth.org.
  • Robinson M; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Morris SA; Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Jandrisevits E; Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Lopes KE; Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Hamilton A; Molecular Biology and Genomics Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Steuerwald N; Molecular Biology and Genomics Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Druhan LJ; Hematology/Oncology Translational Research Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Avalos B; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Copelan E; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Ghosh N; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Grunwald MR; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Pharmacogenomics J ; 23(6): 201-209, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37925536

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Antifúngicos Límite: Humans Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Antifúngicos Límite: Humans Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos